Psychiatry

William H. Wilson, M.D.

Recent Publications:

  1. Wilson WH, Bigelow DA: Brain Activation during affective visual cues in schizophrenia: A pilot study using fMRI. Journal of Clinical Psychopharmacology, 24(4):450-452, 2004.
  2. Wilson WH., A Visual Guide to Expected Blood Levels of Long-Acting Injectable Risperidone in Clinical Practice. Psychiatric Practice, 10:393, 2004.
  3. Wilson WH, Bigelow DA. Homosexuality. eMedicine Journal [online serial]. (http://www.emedicine.com/33), 2001.
  4. Wilson WH, Trott K. Criminality Associated with Mental Illness. eMedicine Journal [online serial]. (http://www.emedicine.com/34), 2001.
  5. Bloom JD, Wilson WH. Effective prevention of criminality and violence among persons suffering from schizophrenia. In: Violence, Crime, and Mentally Disordered Offenders: Concepts and Methods for Effective Treatment and Prevention, S Hodgins (ed) London, John Wiley & Sons, 2000.
  6. Harris DM, Wilson WH, Hamer A. Pharmacological Interventions for Adults. In: Advanced Abnormal Psychology, 2nd Ed, M Herson and VD van Hasselt (eds), New York, Plenum Press, 2000.
  7. Wilson WH. Neuroscientific Research in Mental Health. In: Mental Health Policy and Practice Today, TR Watkins and JW Callicutt (eds), Thousand Oaks (CA): Sage Publications, 1997.
  8. Wilson WH. Time required for initial improvement during clozapine treatment of refractory schizophrenia. American Journal of Psychiatry 153(7): 951-2, Jul 1996.
  9. Kinzie JD, Hancey J, Wilson WH, Hartner J. Paroxetine and offenders: a pilot study. International Journal of Offender Therapy and Comparative Criminology 40: 285-292, 1996.
  10. Cutler DL, Wilson WH, Pollack DA, Godard SA. Training in Community Psychiatry. In: Practicing Psychiatry in the Community, JV Vaccaro and GH Clark (eds), 1996.
  11. Wilson WH, Claussen AM. 18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital. Psychiatric Services 46(4):386-9, Apr 1995.
  12. Wilson WH. Do anticonvulsants hinder clozapine treatment? Biological Psychiatry 37(2): 132-3, 15 Jan 1995.
  13. Wolfe M, Wolfe S, Wilson WH. Clozapine in Russia: a review of the clincial research literature. Psychiatric Services. 3(46): 256-259, 1995.
  14. Wilson WH, Claussen AM. Seizures associated with clozapine treatment in a state hospital. Journal of Clinical Psychiatry. 55(5): 184-8, May 1994.
  15. Wilson WH. The Fifth Psychoactive Drug Usage Guide. Journal of Clinical Psychiatry. 55(1): 34-5, Jan 1994.
  16. Wilson WH. Perspectives from the United States: comments on Shepard's 'Beyond the Mental Hospital'. Community Mental Health Journal. 1994.
  17. Wilson WH. Open clozapine treatment follwoing a controlled clinical trial of lithium augmentation of haloperidol for refractory schizophrenia. Lithium. 4:113-114, 1994.
  18. Wilson WH. Reply to WH Reid, The Fifth Psychoactive Drug Usage Guide. Journal of Clinical Psychiatry. 55(12): 34, 1994.
  19. Wilson WH. Response to FW Becker's 'The politics of closing state mental hospitals. Community Mental Health Journal. 29: 115-117, 1993.
  20. State Hospital Curriculum: Public Academic Liaison for Psychiatric Education. Administration and Policy in Mental Health. 20: 459-469, 1993.
  21. Lippincott RL, Wilson WH, Godard SL, Cutler DL, Angel R. Disseminating the partnership: The Pew Memorial Trust State-University Collaboration Project. Administration and Policy in Mental Health. 20: 471-479, 1993.
  22. Wilson WH. Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial. Psychopharmacology. 111(3): 359-66, 1993.
  23. Cutler DL, Wilson WH, Godard S, Pollack D. Collaboration for training. Administration and Policy in Mental Health. 20: 448-458, 1993.
  24. Schalk DC, Wilson WH. Impact of clozpine on medication use in a state hospital. Hospital Pharmacy. 28(7): 647-653, 1993.
  25. Wilson WH, Claussen AM. Novel antipsychotic medications, Hope for the future. Innovations and Research. 2(2): 7-15, 1993.
  26. Hansen TE, Lowe MK, Wilson WH, Keck PE, Keepers GA, Munetz MR. Integrating research into clinical settings. Innovations and Research. 2(2): 35-42, 1993.
  27. Wilson WH. Rationing clozapine in a state hospital, response to Backlar. Health Care Ethics Committee Forum. 5(5): 319-321, 1993.
  28. Wilson WH. Clarification regarding new antipsychotic medications. Innovations and Research. 2(4): 2, 1993.
  29. Wilson WH. Clinical review of clozapine treatment in a state hospital. Hospital and Community Psychiatry. 43(7): 700-3, Jul 1992.
  30. Wilson WH. Psychiatric education in the state hospital: a current approach. Community Mental Health Journal. 28(1): 51-9; discussion 61-, Feb 1992.
  31. Wilson WH. Response to Kahn and Kahn, Group treatment assignment for outpatients with schizophrenia. Community Mental Health Journal. 28: 551-553, 1992.
  32. Wilson WH, Stout DA. The spectrum of response to clozapine treatment. Annals of Clinical Psychiatry. 4: 201-206, 1992.
  33. de Leon J, Wilson WH, Simpson GM. Negative symptoms, defect state and Huber's basic symptoms: a comparison of the concepts. Psychiatric Quarterly. 62(4): 277-98, Winter 1991.
  34. Wilson WH, Diamond RJ, Factor RM. The chronically mentally ill group treatment for individuals with schizophrenia. Community Mental Health Journal. 26(4): 361-72, Aug 1990.
  35. Wilson, WH, Simpson, GS. Pharmacotherapy (book chapter), In: Handbook of Comparative Treatments, AS Bellack and M Hersen (eds.), New York: John Wiley and Sons, 1990.
  36. Wilson WH. Reassessment of state hospital patients diagnosed with schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences. 1(4): 394-7, 1989.
  37. Wilson WH. Diagnostic consultation to a state hospital. Hospital and Community Psychiatry. 40(12): 1290-3, Dec 1989.
  38. de Leon J, Wilson WH, Simpson GM. Measurement of negative symptoms in schizophrenia. Psychiatric Developments. 7(3): 211-34, Autumn 1989.
  39. Simpson GS, Wilson WH. Strategies for Treating Nonresponding Schizophrenics. In: Schizophrenia: a Scientific Progress, S.C. Schulz and C.A. Tamminga (eds), Oxford. 351-357, 1989.
  40. Josiassen RC, Yadalam K, Johnson MM, Singh H, Wilson WH. Are somatosensory ERP abnormalities related to changes in brain morphology? Poster presented at the American College of Neuropsychopharmacology Annual Meeting, 1989
  41. Josiassen RC, Johnson M, Singh H, Wilson WH.Early somatosensory event-related potentials in schizophrenia. Paper presented at the Society for Research in Psychopathology, 3rd annual meeting, Harvard University, 10 Nov 1988.
  42. Schulz SC, Schulz PM, Wilson WH. Medication treatment of schizotypical personality disorder. Journal of Personality Disorders. 2: 1-13, 1988.
  43. Wilson WH.Re-evaluation of chronically ill psychiatric patients. Journal of Clinical Psychiatry. 49: 413-414, 1988.
  44. Diamond RJ, Wilson WH, Factor RM. Group therapy in psychiatric rehabilitation. Paper presented at the American Psychiatric Association Annual Meeting, Toronto, 1988.
  45. Wilson WH. PIP syndrome. Journal of Clinical Psychiatry. 48(4): 173, Apr 1987.
  46. Wilson WH.Psychosis or Voodoo? A Case Report. Clinical Psychiatric Quarterly. 10: 12-13, 1987.
  47. Wilson WH. Lithium in schizophrenia. Hospital and Community Psychiatry. 37(12): 1267, Dec 1986.
  48. Wilson WH, Diamond RJ, Factor RM. A psychotherapeutic approach to task-oriented groups of severely ill patients. Yale Journal of Biology and Medicine. 58(4): 363-72, 1985.
  49. Wilson WH, Jefferson JW. Thyroid disease, behavior, and psychopharmacology. Psychosomatics. 26: 481-485, 1985.
  50. Wilson WH, Weiler SJ. Case report of phenothiazine-induced torsade de pointes. American Journal of Psychiatry. 141(10): 1265-6, Oct 1984

  51. Wilson WH. Catatonia and encephalopathy following a disulfiram overdose. Wisconsin Medical Journal. 83(9): 15-6, Sep 1984.
  52. Wilson WH. Disulfiram and encephalopathy. Hospital and Community Psychiatry. 35(5): 496-7, May 1984.
  53. Wilson WH. Thioridazine and QT prolongation. Journal of Clinical Psychiatry. 5: 127, 1984.
  54. Wilson WH. An approach to group therapy with severely ill patients. Paper presented at the VIIIth International Symposium on the Psychotherapy of Schizoprhenia, Yale University, New Haven CT. , 1984.
Faculty Page Research Projects


OHSU | Faculty | Training | Grand Rounds | Psychiatry